Viewing nowCombinationDucor Tablet 60/5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Korea Nelson Pharmaceutical Co., Ltd.

MFDS item code 202300101 · Approved 2023.01.06
Treatment of essential hypertension not controlled with fimasartan monotherapy
Pimasartan potassium is used as an add-on treatment for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy, effectively lowering and controlling blood pressure. This helps reduce the risk of cardiovascular diseases and aids in blood pressure management.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams monotherapy. ㆍ 60/2.5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy. ㆍ 60/5 milligrams: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams monotherapy or this medicine 60/2.5 milligrams. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 milligrams. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's active ingredients or similar class medications, pregnant or lactating women, patients undergoing renal dialysis, patients with severe liver impairment, patients with obstructed bile ducts, certain renal and diabetic patients, lactose intolerant patients, patients with severe aortic stenosis, and those in a state of shock should not take this medication. Patients with low blood volume or sodium, impaired kidney function, renal artery hypertension, aortic or mitral stenosis, primary aldosteronism, severe hypotension, elderly patients, and those with allergies to specific pigments should use this medication cautiously. Side effects such as dizziness, headache, facial swelling, urination disorders, insomnia, and flushing may occur while taking this medication; in rare cases, serious kidney problems or blood pressure drops may arise, necessitating immediate consultation with a healthcare provider if abnormal symptoms manifest. Patients with hypotension or electrolyte imbalances should be closely monitored during early treatment, as there is a risk of excessive blood pressure reduction. This medication may interact with other antihypertensive agents, certain diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc.; thus, it is crucial to inform healthcare providers of any other medications taken concurrently. Pregnant and lactating women should consult a physician before taking this medication and are advised to avoid it whenever possible. The safety and efficacy of this medication has not been established in children and adolescents under 18 years of age; therefore, use is not recommended. Elderly patients do not require special dosage adjustments, but may have heightened sensitivity, so caution is necessary. Patients with severely impaired liver function should not take this medication, and in the case of overdose, immediate emergency measures should be obtained due to the potential for severe hypotension or cardiac issues. This medication should be kept out of reach of children and should not be transferred to another container, as it may compromise quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a container that blocks light. Additionally, it is important to store the medication at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.
Orange rectangular film-coated tablet with rounded corners
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Korea Nelson Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.